MADgic™ Pediatric Laryngo-Tracheal Mucosal Atomization Device - without Syringe
The MADgic™ Laryngo-Tracheal Mucosal Atomization Device offers a needle-free, versatile choice to administer medication* across the entire upper airway and beyond the vocal cords.
Key Features include:
• Fine atomized spray for direct coverage of nose, pharynx, larynx, and trachea (approximately 14-70 microns in size)
• Narrow, malleable stylet easily reaches vocal cords and conforms to patient anatomy
• Adapts to any luer-lock syringe
• Not prefilled, allowing customizable medication selection and dosing.
Reliable Intubation
• Helps to facilitate conditions for intubation, especially in difficult, awake, or pediatric cases. (1,2)
Managing Emergence
• Effective topicalization supports smoother emergence from general anesthesia (3-5)
*For use with drugs approved for intranasal and oropharyngeal delivery.
References: -
Xue, F.S., et al. Topical anaesthesia of the airway using trachlight™ and MADgic™ Atomizer in patients with predicted difficult tracheal intubation. British Journal of Anaesthesia, 2007;99(6):920-921
- Xue, Fu S., He P. Liu, et al. Spray-as-you-go airway topical anesthesia in patients with a difficult airway: A randomized, double-blind comparison of 2% and 4% lidocaine. Anesth Analg, 2009;108(2):536-543
- Minogue, Sean C., et al. Laryngotracheal topicalization with lidocaine before intubation decreases the incidence of coughing on emergence from general anesthesia. Anesthesia & Analgesia, 2004;99(4):1253-1257
- Diachun, Carol Ann, et al. Suppression of cough during emergence from general anesthesia: Laryngotracheal lidocaine through a modified endotracheal tube. Journal of Clinical Anesthesia, 2001;13(6):447-451
- Staffel, J. G., et al. The prevention of postoperative stridor and laryngospasm with topical lidocaine. Arch Otolaryngol Head Neck Surg, 1991;117(10):1123-1128
MC-007640Rev1